Search

Displaying results 3831 - 3840 of 4860 in total
  1. Drug

    KITE-585

    go.drugbank.com/drugs/DB17409
    Investigational

    It is being investigated in the treatment of multiple myeloma.

  2. Drug

    NP-6A4

    go.drugbank.com/drugs/DB17599
    Experimental

    It has an Orphan Drug designation from the FDA for pediatric cardiomyopathy.[A258523]

  3. Drug

    Eftansomatropin alfa

    go.drugbank.com/drugs/DB18460
    Investigational

    [L48275] It is under investigation for the treatment of growth hormone deficiency.

  4. Drug

    9,10-Deepithio-9,10-Didehydroacanthifolicin

    go.drugbank.com/drugs/DB02169
    Experimental

    It is also a potent tumor promoter. (Thromb Res 1992;67(4):345-54 & Cancer Res 1993;53(2):239-41)

  5. Drug

    Brasofensine

    go.drugbank.com/drugs/DB04857
    Experimental

    Brasofensine is an orally administered dopamine reuptake inhibitor being developed for the treatment of Parkinson's Disease. Phase I/II trials for brasofensine have been completed in the U.K. In November 2001, NeuroSearch confirmed that ...

  6. Drug

    GFT14

    go.drugbank.com/drugs/DB05061
    Experimental

    GFT14 is a new class of medicaction for treatment of cardiometabolic disease. GFT14 aims to target mixed dyslipidemia of type IIb (high levels of triglycerides and LDL-C) as one of the major indications of cardiometabolic disease. GFT14 ...

  7. Drug

    Cedazuridine

    go.drugbank.com/drugs/DB15694
    ApprovedInvestigational

    Myelodysplastic syndromes (MDS) are a group of hematopoietic neoplasms that give rise to variable cytopenias progressing to secondary acute myeloid leukemia (sAML), which is invariably fatal if untreated. Hypomethylating agents such as d...

  8. Drug

    Rotenone

    go.drugbank.com/drugs/DB11457
    ExperimentalVet approved

    It has broad spectrum insecticide and pesticide activity and is also toxic to fish.

  9. Drug

    Tecadenoson

    go.drugbank.com/drugs/DB04954
    Investigational

    It is being developed by CV Therapeutics, Inc.

  10. Drug

    SLV319

    go.drugbank.com/drugs/DB05077
    Experimental

    It is developed for the treatment of obesity and other metabolic disorders.